Tag Archives: (BAYRY)

The Aspirin Standard

In 1899, Bayer (BAYRY) patented acetylsalicylic acid – what we now call aspirin. This “miracle drug” then became the cornerstone of one of the most powerful pharmaceutical empires the world had ever seen. Unfortunately for Bayer, by 1917, they had to give up the patent as part of World War I reparations. Poof. Gone. That’s […]

Even A Pig Could Make Money Here

I was camped out in Kyiv the other month when news of Organon’s (OGN) earnings hit my phone. While Russian drones buzzed overhead, I was studying pharmaceutical balance sheets—talk about surreal. Did I mention I’ve led a strange life? In mid-February, Organon pleasantly surprised me with Q4 2024 results. Hadlima, their biosimilar to Humira, rocketed […]